Literature DB >> 3342514

Clinical application of serum bilirubin fractionation by simplified liquid chromatography.

Y Adachi1, H Inufusa, M Yamashita, A Kambe, K Yamazaki, Y Sawada, T Yamamoto.   

Abstract

Serum bilirubin was fractionated by a new reversed-phase "high-performance" liquid-chromatographic (HPLC) procedure, on Micronex RP-30, a polyacryl ester. The five fractions were: delta (delta-bilirubin, B delta), gamma (bilirubin diglucuronide, BDG), beta (bilirubin monoglucuronide, BMG), beta' [(Z,E)- and (or) (E,Z)-bilirubin IX alpha], and alpha [(Z,Z)-bilirubin IX alpha]. We found close correlation with results of the modified HPLC fractionation of Lauff et al. (J Chromatogr 1981;226:391-402), except for the beta' fraction, which was eluted after beta. The Micronex HPLC involves a simple pretreatment of serum samples, in contrast with the complex preparation described by Lauff et al., and is convenient for routine use in the clinical evaluation of hyperbilirubinemia. We could quantify B delta, BDG, BMG, and unconjugated bilirubin even in sera with normal values for total-bilirubin concentrations. Photoderivatives of bilirubin such as the beta' fraction could be separated and quantified by the same procedure, making the method feasible for pediatric research.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342514

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Novel assay for measuring serum conjugated bilirubin and its clinical relevance.

Authors:  Y Morimoto; T Ishihara; M Takayama; M Kaito; Y Adachi
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Type II crigler-Najjar syndrome with intrahepatic cholestasis.

Authors:  A Kagita; Y Adachi; A Kambe; T Kamisako; T Yamamoto
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

3.  Human serum bilirubin fractionation in various hepatobiliary diseases by the newly developed high performance liquid chromatography.

Authors:  Y Adachi; H Inufusa; M Yamashita; A Kambe; K Yamazaki; Y Sawada; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1988-06

Review 4.  Diagnostic methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments.

Authors:  Christian V Hulzebos; Libor Vitek; Carlos D Coda Zabetta; Aleš Dvořák; Paul Schenk; Eline A E van der Hagen; Christa Cobbaert; Claudio Tiribelli
Journal:  Pediatr Res       Date:  2021-05-04       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.